
zzso play important roles in the natural history of breast zzso zzso therapies have been developed to reduce zzso levels or to block zzso through zzso receptors zzso These therapies include zzso selective zzso zzso zzso zzso zzso zzso zzso and selective zzso zzso zzso zzso All have proven clinical efficacy in zzso women with zzso breast cancer and can be effective in the zzso and zzso settings, and in the management of advanced zzso This range of zzso therapies offers the opportunity for zzso benefit from treatment and delaying zzso zzso by combining the different classes of drugs or by using them zzso zzso of the potential clinical benefits of zzso or sequential zzso therapies should be based on considerations of efficacy and safety profiles, mechanisms of zzso and effects on zzso zzso Evidence from zzso models and from zzso clinical trials in patients with zzso breast cancer suggests that zzso zzso therapies are no more effective than zzso zzso However, using zzso either as initial therapy or zzso after tamoxifen appears to produce more benefits beyond the use of tamoxifen zzso there are no proven zzso for the planned, sequential use of the full range of zzso therapies, particularly for the majority of patients who present with early breast zzso zzso zzso clinical trials are needed to determine the best use of therapies in particular settings, taking into account the spectrum of molecular zzso in different zzso 

